Preprint Article Version 1 This version is not peer-reviewed

Pharmacist-Led Identification of Discrepancies and Drug Related Problems within Two Surgery Wards: A Prospective Observational Study

Version 1 : Received: 11 July 2024 / Approved: 12 July 2024 / Online: 15 July 2024 (13:06:02 CEST)

How to cite: Faccioli, F. F.; Mengato, D.; Pivato, L.; Temporin, F.; Torni, F.; Battistutta, C.; Sarzo, G.; Iacobone, M.; Realdon, N.; Venturini, F. Pharmacist-Led Identification of Discrepancies and Drug Related Problems within Two Surgery Wards: A Prospective Observational Study. Preprints 2024, 2024071083. https://doi.org/10.20944/preprints202407.1083.v1 Faccioli, F. F.; Mengato, D.; Pivato, L.; Temporin, F.; Torni, F.; Battistutta, C.; Sarzo, G.; Iacobone, M.; Realdon, N.; Venturini, F. Pharmacist-Led Identification of Discrepancies and Drug Related Problems within Two Surgery Wards: A Prospective Observational Study. Preprints 2024, 2024071083. https://doi.org/10.20944/preprints202407.1083.v1

Abstract

Background: Medication errors often stem from incomplete or incorrect transfer of drug information during reviews. To enhance medication review processes, a collaborative healthcare team, including a pharmacist in the surgical ward, is essential. This study aimed to identify the frequency and the kind of intentional and unintentional discrepancies related to the prescriptions within two surgical wards. Methods: A prospective observational study was conducted among adult patients admitted to two surgical settings. The patients were selected between May 30th and November 30th, 2021. The study followed a three-phase structure: patient selection, medication review to identify discrepancies and DRPs, and the detection of any such issues in the discharge letter. Results: The most frequent types of discrepancies collected were substitutions (60.9%) for the Endocrinological Surgery and omissions for General Surgery (53.4%). In Endocrinological Surgery, 45.9% of cases exhibited class C drug interactions. In General Surgery, class D drug interactions were predominantly observed (54.1%), with 93.3% attributed to drugs carrying an elevated risk of prolonging the QT interval. Conclusions: Frequently, the medication review process is superficially carried out, introducing errors that may adversely affect patient health. This study explores the potential positive impact of involving the clinical pharmacist in identifying and managing discrepancies and DRPs.

Keywords

clinical pharmacist; pharmacist intervention; surgery; medication review; potentially inappropriate medication; drug related problems; drug interactions

Subject

Medicine and Pharmacology, Surgery

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.